JP2008516004A5 - - Google Patents

Download PDF

Info

Publication number
JP2008516004A5
JP2008516004A5 JP2007543041A JP2007543041A JP2008516004A5 JP 2008516004 A5 JP2008516004 A5 JP 2008516004A5 JP 2007543041 A JP2007543041 A JP 2007543041A JP 2007543041 A JP2007543041 A JP 2007543041A JP 2008516004 A5 JP2008516004 A5 JP 2008516004A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
salt
radioisotope
granule
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007543041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008516004A (ja
JP5635727B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/035921 external-priority patent/WO2007050050A2/en
Publication of JP2008516004A publication Critical patent/JP2008516004A/ja
Publication of JP2008516004A5 publication Critical patent/JP2008516004A5/ja
Application granted granted Critical
Publication of JP5635727B2 publication Critical patent/JP5635727B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007543041A 2004-10-07 2005-10-06 チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法 Expired - Fee Related JP5635727B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61680504P 2004-10-07 2004-10-07
US60/616,805 2004-10-07
PCT/US2005/035921 WO2007050050A2 (en) 2004-10-07 2005-10-06 Thiazolyl mglur5 antagonists and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014184615A Division JP2015013885A (ja) 2004-10-07 2014-09-10 チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法

Publications (3)

Publication Number Publication Date
JP2008516004A JP2008516004A (ja) 2008-05-15
JP2008516004A5 true JP2008516004A5 (https=) 2014-10-30
JP5635727B2 JP5635727B2 (ja) 2014-12-03

Family

ID=37968242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007543041A Expired - Fee Related JP5635727B2 (ja) 2004-10-07 2005-10-06 チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法
JP2014184615A Pending JP2015013885A (ja) 2004-10-07 2014-09-10 チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014184615A Pending JP2015013885A (ja) 2004-10-07 2014-09-10 チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法

Country Status (9)

Country Link
US (3) US7879882B2 (https=)
EP (2) EP2380889B1 (https=)
JP (2) JP5635727B2 (https=)
CN (1) CN101223166B (https=)
AT (1) ATE520692T1 (https=)
AU (1) AU2005336513B2 (https=)
CA (1) CA2583572C (https=)
ES (1) ES2369783T3 (https=)
WO (1) WO2007050050A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879882B2 (en) * 2004-10-07 2011-02-01 Merck Sharp & Dohme Corp. Thiazolyl mglur5 antagonists and methods for their use
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
TW201124391A (en) * 2009-10-20 2011-07-16 Lundbeck & Co As H 2-substituted-ethynylthiazole derivatives and uses of same
WO2011092290A1 (en) 2010-02-01 2011-08-04 Novartis Ag Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
US8420661B2 (en) * 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
US8772300B2 (en) * 2011-04-19 2014-07-08 Hoffmann-La Roche Inc. Phenyl or pyridinyl-ethynyl derivatives
CA2829171C (en) * 2011-04-26 2019-02-26 F. Hoffmann-La Roche Ag Pyrazolidin-3-one derivatives
PL2702051T3 (pl) * 2011-04-26 2015-08-31 Hoffmann La Roche Pochodne etynylu jako pozytywne allosteryczne modulatory mglur5
CA2900300A1 (en) 2013-02-07 2014-08-14 Merck Patent Gmbh Substituted acetylene derivatives and their use as positive allosteric modulators of mglur4
UA116023C2 (uk) * 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
WO2015188368A1 (en) 2014-06-13 2015-12-17 Merck Sharp & Dohme Corp. Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles
LT3303316T (lt) 2015-06-03 2020-05-11 F. Hoffmann-La Roche Ag Etinilo dariniai
JP7312749B2 (ja) 2017-08-04 2023-07-21 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングをモジュレートする方法および組成物
JP7551629B2 (ja) 2019-02-05 2024-09-17 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
WO2020163405A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7603594B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
JP7603595B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774138B2 (en) 1999-08-31 2004-08-10 Merck & Co., Inc. Thiazolyl(pyridyl)ethyne compounds
US6956049B1 (en) 1999-08-31 2005-10-18 Merck & Co., Inc. Methods of modulating processes mediated by excitatory amino acid receptors
US7462619B2 (en) 1999-08-31 2008-12-09 Merck & Co., Inc. Pyridazine, pyrimidine and pyrazine ethyne compounds
EP1214303A1 (en) * 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof
US7365074B2 (en) 1999-08-31 2008-04-29 Merck & Co., Inc. Pyridazine, pyrimidine and pyrazine ethyne compounds
US6903005B1 (en) 2000-08-30 2005-06-07 Micron Technology, Inc. Method for the formation of RuSixOy-containing barrier layers for high-k dielectrics
US6551270B1 (en) 2000-08-30 2003-04-22 Snowden Pencer, Inc. Dual lumen access port
WO2004038374A2 (en) * 2002-10-24 2004-05-06 Merck & Co., Inc. Alkyne derivatives as tracers for metabotropic glutamate receptor binding
US7879882B2 (en) * 2004-10-07 2011-02-01 Merck Sharp & Dohme Corp. Thiazolyl mglur5 antagonists and methods for their use

Similar Documents

Publication Publication Date Title
JP2008516004A5 (https=)
JP2021063088A5 (https=)
JP2006526031A5 (https=)
JP2009502743A5 (https=)
JP2012031147A5 (https=)
JP2020097577A5 (https=)
JP2010077141A5 (https=)
JP2018534348A5 (https=)
JP2013519632A5 (https=)
JP2005518413A5 (https=)
JP2007302683A5 (https=)
JP2010501534A5 (https=)
JP2016065086A5 (https=)
JP2016006096A5 (https=)
JP2012502037A5 (https=)
JP2011527299A5 (https=)
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
JP2008519768A5 (https=)
JP2008513510A5 (https=)
BR0111868A (pt) Composições farmacêuticas
JP2004532828A5 (https=)
JP2005509503A5 (https=)
JP2009517411A5 (https=)
JP2010500284A5 (https=)
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient